High expression of JAM2 indicates better prognosis and immunotherapy response in breast cancer
Y. Peng, C. Qu, Y. Zhang, B. Zong, Y. Fu, J. Xie, S. Liu
This study identifies JAM2 as a prognostic marker and potential predictor of immunotherapy response in breast cancer using multi-database analysis.
bioRxiv · Dec 11, 2020 · PreprintCancer Biology